At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Implementation of Carrier Status Using Next Generation Sequencing
In Brief
A clinical study evaluating Whole Genome Sequencing and Carrier status testing for Genetic Disorders. Completed, enrolled 384 participants across 1 site.
Detailed Summary
This study is conducting a randomized controlled trial (RCT) with up to 400 subjects (women \& partners) seeking pre-conception carrier testing to assess the impact of the program using Whole Genome Sequencing (WGS). 1. The investigators hypothesize that whole genome sequencing will increase the detection of carrier status for Mendelian recessive and x-linked conditions. 2. The investigators hypothesize that parents will act on the knowledge of their carrier status by making different reproductive choices than parents who do not receive this information. 3. The investigators hypothesize that the psychosocial risks are increased among parents who receive expanded carrier screening using Next Generation Sequencing (NGS) compared with usual care.
Study Details
Timeline
Interventions
Participants will receive Whole Genome Sequencing
Carrier status testing